Report Detail

Other Global Pharmaceutical Contract Development and Manufacturing Market Size, Status and Forecast 2019-2025

  • RnM3664904
  • |
  • 13 August, 2019
  • |
  • Global
  • |
  • 92 Pages
  • |
  • QYResearch
  • |
  • Other

In 2018, the global Pharmaceutical Contract Development and Manufacturing market size was xx million US$ and it is expected to reach xx million US$ by the end of 2025, with a CAGR of xx% during 2019-2025.

This report focuses on the global Pharmaceutical Contract Development and Manufacturing status, future forecast, growth opportunity, key market and key players. The study objectives are to present the Pharmaceutical Contract Development and Manufacturing development in North America, Europe, China, Japan, Southeast Asia, India and Central and South America.

The key players covered in this study
Thermo Fisher Scientific Inc.
Catalent, Inc.
Lonza Group Ltd
Recipharm AB
Vetter Pharma International GMBH
FAMAR Health Care Services
AbbVie Inc.
Aenova Group
Consort Medical plc
Almac Group
Siegfried Holding AG
Boehringer Ingelheim International GmbH 
Evonik Industries AG

Market segment by Type, the product can be split into
Pharmaceutical Manufacturing Services
Biologics Manufacturing Services
Drug Development Services

Market segment by Application, split into
Big Pharma
Small Pharma
Generic Pharma
CRO

Market segment by Regions/Countries, this report covers
North America
Europe
China
Japan
Southeast Asia
India
Central and South America

The study objectives of this report are:
To analyze global Pharmaceutical Contract Development and Manufacturing status, future forecast, growth opportunity, key market and key players.
To present the Pharmaceutical Contract Development and Manufacturing development in North America, Europe, China, Japan, Southeast Asia, India and Central and South America.
To strategically profile the key players and comprehensively analyze their development plan and strategies.
To define, describe and forecast the market by product type, market and key regions.

In this study, the years considered to estimate the market size of Pharmaceutical Contract Development and Manufacturing are as follows:
History Year: 2014-2018
Base Year: 2018
Estimated Year: 2019
Forecast Year 2019 to 2025
For the data information by region, company, type and application, 2018 is considered as the base year. Whenever data information was unavailable for the base year, the prior year has been considered.


Table of Contents

    1 Report Overview

    • 1.1 Study Scope
    • 1.2 Key Market Segments
    • 1.3 Players Covered
    • 1.4 Market Analysis by Type
      • 1.4.1 Global Pharmaceutical Contract Development and Manufacturing Market Size Growth Rate by Type (2014-2025)
      • 1.4.2 Pharmaceutical Manufacturing Services
      • 1.4.3 Biologics Manufacturing Services
      • 1.4.4 Drug Development Services
    • 1.5 Market by Application
      • 1.5.1 Global Pharmaceutical Contract Development and Manufacturing Market Share by Application (2019-2025)
      • 1.5.2 Big Pharma
      • 1.5.3 Small Pharma
      • 1.5.4 Generic Pharma
      • 1.5.5 CRO
    • 1.6 Study Objectives
    • 1.7 Years Considered

    2 Global Growth Trends

    • 2.1 Pharmaceutical Contract Development and Manufacturing Market Size
    • 2.2 Pharmaceutical Contract Development and Manufacturing Growth Trends by Regions
      • 2.2.1 Pharmaceutical Contract Development and Manufacturing Market Size by Regions (2019-2025)
      • 2.2.2 Pharmaceutical Contract Development and Manufacturing Market Share by Regions (2014-2019)
    • 2.3 Industry Trends
      • 2.3.1 Market Top Trends
      • 2.3.2 Market Drivers
      • 2.3.3 Market Challenges
      • 2.3.4 Porter’s Five Forces Analysis

    3 Market Share by Key Players

    • 3.1 Pharmaceutical Contract Development and Manufacturing Market Size by by Players
      • 3.1.1 Global Pharmaceutical Contract Development and Manufacturing Revenue by by Players (2014-2019)
      • 3.1.2 Global Pharmaceutical Contract Development and Manufacturing Revenue Market Share by by Players (2014-2019)
      • 3.1.3 Global Pharmaceutical Contract Development and Manufacturing Market Concentration Ratio (CR5 and HHI)
    • 3.2 Pharmaceutical Contract Development and Manufacturing Key Players Head office and Area Served
    • 3.3 Key Players Pharmaceutical Contract Development and Manufacturing Product/Solution/Service
    • 3.4 Date of Enter into Pharmaceutical Contract Development and Manufacturing Market
    • 3.5 Mergers & Acquisitions, Expansion Plans

    4 Breakdown Data by Type and Application

    • 4.1 Global Pharmaceutical Contract Development and Manufacturing Market Size by Type (2014-2019)
    • 4.2 Global Pharmaceutical Contract Development and Manufacturing Market Size by Application (2014-2019)

    5 North America

    • 5.1 North America Pharmaceutical Contract Development and Manufacturing Market Size (2014-2019)
    • 5.2 Pharmaceutical Contract Development and Manufacturing Key Players in North America
    • 5.3 North America Pharmaceutical Contract Development and Manufacturing Market Size by Type
    • 5.4 North America Pharmaceutical Contract Development and Manufacturing Market Size by Application

    6 Europe

    • 6.1 Europe Pharmaceutical Contract Development and Manufacturing Market Size (2014-2019)
    • 6.2 Pharmaceutical Contract Development and Manufacturing Key Players in Europe
    • 6.3 Europe Pharmaceutical Contract Development and Manufacturing Market Size by Type
    • 6.4 Europe Pharmaceutical Contract Development and Manufacturing Market Size by Application

    7 China

    • 7.1 China Pharmaceutical Contract Development and Manufacturing Market Size (2014-2019)
    • 7.2 Pharmaceutical Contract Development and Manufacturing Key Players in China
    • 7.3 China Pharmaceutical Contract Development and Manufacturing Market Size by Type
    • 7.4 China Pharmaceutical Contract Development and Manufacturing Market Size by Application

    8 Japan

    • 8.1 Japan Pharmaceutical Contract Development and Manufacturing Market Size (2014-2019)
    • 8.2 Pharmaceutical Contract Development and Manufacturing Key Players in Japan
    • 8.3 Japan Pharmaceutical Contract Development and Manufacturing Market Size by Type
    • 8.4 Japan Pharmaceutical Contract Development and Manufacturing Market Size by Application

    9 Southeast Asia

    • 9.1 Southeast Asia Pharmaceutical Contract Development and Manufacturing Market Size (2014-2019)
    • 9.2 Pharmaceutical Contract Development and Manufacturing Key Players in Southeast Asia
    • 9.3 Southeast Asia Pharmaceutical Contract Development and Manufacturing Market Size by Type
    • 9.4 Southeast Asia Pharmaceutical Contract Development and Manufacturing Market Size by Application

    10 India

    • 10.1 India Pharmaceutical Contract Development and Manufacturing Market Size (2014-2019)
    • 10.2 Pharmaceutical Contract Development and Manufacturing Key Players in India
    • 10.3 India Pharmaceutical Contract Development and Manufacturing Market Size by Type
    • 10.4 India Pharmaceutical Contract Development and Manufacturing Market Size by Application

    11 Central and South America

    • 11.1 Central and South America Pharmaceutical Contract Development and Manufacturing Market Size (2014-2019)
    • 11.2 Pharmaceutical Contract Development and Manufacturing Key Players in Central and South America
    • 11.3 Central and South America Pharmaceutical Contract Development and Manufacturing Market Size by Type
    • 11.4 Central and South America Pharmaceutical Contract Development and Manufacturing Market Size by Application

    12 International Players Profiles

    • 12.1 Thermo Fisher Scientific Inc.
      • 12.1.1 Thermo Fisher Scientific Inc. Company Details
      • 12.1.2 Company Description and Business Overview
      • 12.1.3 Pharmaceutical Contract Development and Manufacturing Introduction
      • 12.1.4 Thermo Fisher Scientific Inc. Revenue in Pharmaceutical Contract Development and Manufacturing Business (2014-2019))
      • 12.1.5 Thermo Fisher Scientific Inc. Recent Development
    • 12.2 Catalent, Inc.
      • 12.2.1 Catalent, Inc. Company Details
      • 12.2.2 Company Description and Business Overview
      • 12.2.3 Pharmaceutical Contract Development and Manufacturing Introduction
      • 12.2.4 Catalent, Inc. Revenue in Pharmaceutical Contract Development and Manufacturing Business (2014-2019)
      • 12.2.5 Catalent, Inc. Recent Development
    • 12.3 Lonza Group Ltd
      • 12.3.1 Lonza Group Ltd Company Details
      • 12.3.2 Company Description and Business Overview
      • 12.3.3 Pharmaceutical Contract Development and Manufacturing Introduction
      • 12.3.4 Lonza Group Ltd Revenue in Pharmaceutical Contract Development and Manufacturing Business (2014-2019)
      • 12.3.5 Lonza Group Ltd Recent Development
    • 12.4 Recipharm AB
      • 12.4.1 Recipharm AB Company Details
      • 12.4.2 Company Description and Business Overview
      • 12.4.3 Pharmaceutical Contract Development and Manufacturing Introduction
      • 12.4.4 Recipharm AB Revenue in Pharmaceutical Contract Development and Manufacturing Business (2014-2019)
      • 12.4.5 Recipharm AB Recent Development
    • 12.5 Vetter Pharma International GMBH
      • 12.5.1 Vetter Pharma International GMBH Company Details
      • 12.5.2 Company Description and Business Overview
      • 12.5.3 Pharmaceutical Contract Development and Manufacturing Introduction
      • 12.5.4 Vetter Pharma International GMBH Revenue in Pharmaceutical Contract Development and Manufacturing Business (2014-2019)
      • 12.5.5 Vetter Pharma International GMBH Recent Development
    • 12.6 FAMAR Health Care Services
      • 12.6.1 FAMAR Health Care Services Company Details
      • 12.6.2 Company Description and Business Overview
      • 12.6.3 Pharmaceutical Contract Development and Manufacturing Introduction
      • 12.6.4 FAMAR Health Care Services Revenue in Pharmaceutical Contract Development and Manufacturing Business (2014-2019)
      • 12.6.5 FAMAR Health Care Services Recent Development
    • 12.7 AbbVie Inc.
      • 12.7.1 AbbVie Inc. Company Details
      • 12.7.2 Company Description and Business Overview
      • 12.7.3 Pharmaceutical Contract Development and Manufacturing Introduction
      • 12.7.4 AbbVie Inc. Revenue in Pharmaceutical Contract Development and Manufacturing Business (2014-2019)
      • 12.7.5 AbbVie Inc. Recent Development
    • 12.8 Aenova Group
      • 12.8.1 Aenova Group Company Details
      • 12.8.2 Company Description and Business Overview
      • 12.8.3 Pharmaceutical Contract Development and Manufacturing Introduction
      • 12.8.4 Aenova Group Revenue in Pharmaceutical Contract Development and Manufacturing Business (2014-2019)
      • 12.8.5 Aenova Group Recent Development
    • 12.9 Consort Medical plc
      • 12.9.1 Consort Medical plc Company Details
      • 12.9.2 Company Description and Business Overview
      • 12.9.3 Pharmaceutical Contract Development and Manufacturing Introduction
      • 12.9.4 Consort Medical plc Revenue in Pharmaceutical Contract Development and Manufacturing Business (2014-2019)
      • 12.9.5 Consort Medical plc Recent Development
    • 12.10 Almac Group
      • 12.10.1 Almac Group Company Details
      • 12.10.2 Company Description and Business Overview
      • 12.10.3 Pharmaceutical Contract Development and Manufacturing Introduction
      • 12.10.4 Almac Group Revenue in Pharmaceutical Contract Development and Manufacturing Business (2014-2019)
      • 12.10.5 Almac Group Recent Development
    • 12.11 Siegfried Holding AG
    • 12.12 Boehringer Ingelheim International GmbH
    • 12.13 Evonik Industries AG

    13 Market Forecast 2019-2025

    • 13.1 Market Size Forecast by Product (2019-2025)
    • 13.2 Market Size Forecast by Application (2019-2025)
    • 13.3 Market Size Forecast by Regions
    • 13.4 North America
    • 13.5 Europe
    • 13.6 China
    • 13.7 Japan
    • 13.8 Southeast Asia
    • 13.9 India
    • 13.10 Central and South America

    14 Analyst's Viewpoints/Conclusions

      15 Appendix

      • 15.1 Research Methodology
        • 15.1.1 Methodology/Research Approach
          • 15.1.1.1 Research Programs/Design
          • 15.1.1.2 Market Size Estimation
          • 15.1.1.3 Market Breakdown and Data Triangulation
        • 15.1.2 Data Source
          • 15.1.2.1 Secondary Sources
          • 15.1.2.2 Primary Sources
      • 15.2 Disclaimer

      Summary:
      Get latest Market Research Reports on PharmaceuticalContractDevelopmentandManufacturing. Industry analysis & Market Report on PharmaceuticalContractDevelopmentandManufacturing is a syndicated market report, published as Global Pharmaceutical Contract Development and Manufacturing Market Size, Status and Forecast 2019-2025. It is complete Research Study and Industry Analysis of PharmaceuticalContractDevelopmentandManufacturing market, to understand, Market Demand, Growth, trends analysis and Factor Influencing market.

      Last updated on

      REPORT YOU MIGHT BE INTERESTED

      Purchase this Report

      $3,900.00
      $5,850.00
      $7,800.00
      3,061.50
      4,592.25
      6,123.00
      3,595.80
      5,393.70
      7,191.60
      612,261.00
      918,391.50
      1,224,522.00
      324,129.00
      486,193.50
      648,258.00
      Credit card Logo

      Related Reports


      Reason to Buy

      Request for Sample of this report